1. Scrip
  2. >>Focus On Asia

Takeda Acquires Celiac Venture PvP For Up To $330m

 
• By Ian Haydock

Japanese firm exercises option after promising Phase I results in disorder with no approved drugs, in deal that builds out its celiac pipeline.

Abdominal pain of a young woman. Taken from the front view on a white background. Abdominal pain Menstrual pain of women
Deal Brings Celiac Asset To Takeda • Source: Shutterstock

Takeda Pharmaceutical Co. Ltd. has acquired the private San Diego-based venture PvP Biologics Inc., following promising early clinical results with the university spin-out’s candidate for celiac disease.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Japan

More from Focus On Asia